BIOCRYST PHARMACEUTICALS INC Insider Trading for December 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOCRYST PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOCRYST PHARMACEUTICALS INC for December 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 17 2020 | BCRX | BIOCRYST PHARMACEU ... | Sniecinski Megan | Chief Business Offi ... | Option Exercise | A | 8.31 | 225,000 | 1,869,750 | 225,000 | |
Dec 17 2020 | BCRX | BIOCRYST PHARMACEU ... | Sniecinski Megan | Chief Business Offi ... | Option Exercise | A | 8.31 | 225,000 | 1,869,750 | 225,000 | |
Dec 17 2020 | BCRX | BIOCRYST PHARMACEU ... | Jones Michael L | Exec. Director, Fin ... | Option Exercise | A | 8.31 | 30,000 | 249,300 | 30,000 | |
Dec 17 2020 | BCRX | BIOCRYST PHARMACEU ... | Gayer Charles K | Vice President and ... | Option Exercise | A | 8.31 | 190,000 | 1,578,900 | 190,000 | |
Dec 17 2020 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Option Exercise | A | 8.31 | 280,000 | 2,326,800 | 280,000 | |
Dec 17 2020 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | A | 8.31 | 280,000 | 2,326,800 | 280,000 | |
Dec 17 2020 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | A | 8.31 | 335,000 | 2,783,850 | 335,000 | |
Dec 17 2020 | BCRX | BIOCRYST PHARMACEU ... | Doyle Anthony | Chief Financial Off ... | Option Exercise | A | 8.31 | 332,500 | 2,763,075 | 332,500 | |
Dec 17 2020 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 8.31 | 870,000 | 7,229,700 | 870,000 | |
Dec 17 2020 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | M | 4.15 | 134,278 | 557,254 | 1 | |
Dec 17 2020 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Sell | S | 8.32 | 134,278 | 1,117,193 | 784,086 | 918.4 K to 784.1 K (-14.62 %) |
Dec 17 2020 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | M | 4.15 | 134,278 | 557,254 | 918,364 | 784.1 K to 918.4 K (+17.13 %) |
Dec 15 2020 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Option Exercise | M | 4.15 | 13,741 | 57,025 | 0 | |
Dec 15 2020 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Sell | S | 7.96 | 13,741 | 109,378 | 108,061 | 121.8 K to 108.1 K (-11.28 %) |
Dec 15 2020 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Buy | M | 4.15 | 13,741 | 57,025 | 121,802 | 108.1 K to 121.8 K (+12.72 %) |
Dec 08 2020 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Option Exercise | M | 4.15 | 13,741 | 57,025 | 13,741 | |
Dec 08 2020 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Sell | S | 6.23 | 13,741 | 85,606 | 108,061 | 121.8 K to 108.1 K (-11.28 %) |
Dec 08 2020 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Buy | M | 4.15 | 13,741 | 57,025 | 121,802 | 108.1 K to 121.8 K (+12.72 %) |
Dec 07 2020 | BCRX | BIOCRYST PHARMACEU ... | Jones Michael L | Exec. Director, Fin ... | Option Exercise | A | 5.45 | 5,000 | 27,250 | 5,000 | |
Dec 07 2020 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | A | 5.45 | 17,000 | 92,650 | 17,000 | |
Dec 07 2020 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Option Exercise | A | 5.45 | 17,000 | 92,650 | 17,000 | |
Dec 07 2020 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | A | 5.45 | 17,000 | 92,650 | 17,000 | |
Dec 07 2020 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 3.23 | 157,250 | 507,918 | 157,250 | |
Dec 07 2020 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 5.45 | 25,000 | 136,250 | 25,000 | |
Dec 02 2020 | BCRX | BIOCRYST PHARMACEU ... | HEGGIE THERESA | Director | Grant | A | 5.11 | 978 | 4,998 | 13,386 | 12.4 K to 13.4 K (+7.88 %) |
Dec 02 2020 | BCRX | BIOCRYST PHARMACEU ... | ASELAGE STEVE | Director | Grant | A | 5.11 | 1,956 | 9,995 | 30,569 | 28.6 K to 30.6 K (+6.84 %) |
Dec 02 2020 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 5.11 | 978 | 4,998 | 64,293 | 63.3 K to 64.3 K (+1.54 %) |
Dec 02 2020 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 5.11 | 3,669 | 18,749 | 73,274 | 69.6 K to 73.3 K (+5.27 %) |